Singapore: NCCS scientists successfully target TKI-resistant cancer using exosomes from living cells
The exosomal treatment was able to increase the sensitivity of the resistant cell lines to many different types of TKIs. Remarkably, they were able to achieve the same result in vivo using a mouse model, confirming that it is possible to target EGFR TKI-resistant tumours with this strategy.
